Novel Therapeutic Strategy for Triple Negative Breast Cancer Targeting hERO1-Lα

被引：0
|
作者：
Wada, Asaka [1 ,2 ]
Hirohashi, Yoshihiko [1 ]
Kutomi, Goro [2 ]
Shima, Hiroaki
Murata, Kenji [3 ,4 ]
Kubo, Terufumi [1 ]
Tsukahara, Tomohide [3 ,5 ]
Tamura, Yasuaki [1 ,6 ]
Torigoe, Toshihiko
Takemasa, Ichiro [2 ]
机构：
[1] Sapporo Med Univ, Dept Pathol, Sch Med, Sapporo, Japan
[2] Sapporo Med Univ, Dept Surg, Surg Oncol & Sci, Sapporo, Japan
[3] Sapporo Med Univ, Dept Path, Sapporo, Japan
[4] Princess Margaret Canc Ctr, Toronto, ON, Canada
[5] Sapporo Med Univ, Dept Orthop Surg, Sapporo, Japan
[6] Hokkaido Univ, Dept Mol Therapeut, Sapporo, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-2352
引用
收藏
页码：1486 / 1486
页数：1
相关论文
共 50 条
  • [41] Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer (vol, pg, 2019)
    Xu, Jiangsheng
    Liu, Yunhua
    Li, Yujing
    Wang, Hai
    Stewart, Samantha
    Van der Jeught, Kevin
    Agarwal, Pranay
    Zhang, Yuntian
    Liu, Sheng
    Zhao, Gang
    Wan, Jun
    Lu, Xiongbin
    He, Xiaoming
    NATURE NANOTECHNOLOGY, 2020, 15 (04) : 342 - 342
  • [42] CBP/β-Catenin/FOXM1 Is a Novel Therapeutic Target in Triple Negative Breast Cancer
    Ring, Alexander
    Cu Nguyen
    Smbatyan, Goar
    Tripathy, Debu
    Yu, Min
    Press, Michael
    Kahn, Michael
    Lang, Julie E.
    CANCERS, 2018, 10 (12):
  • [43] Therapeutic Targeting of SFRP2 is a Strategy to Reduce Triple Negative Breast Tumor Growth
    Fontenot, E. M.
    Mumper, R.
    Shen, X.
    Siamakpour-Reihani, S.
    Hilliard, E. G.
    Bone, B.
    Ketelsen, D. P.
    Ross, C.
    Rossi, E. C.
    Patterson, C.
    Kauber-DeMore, N.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S7 - S7
  • [44] Therapeutic targets in triple negative breast cancer
    O'Toole, Sandra A.
    Beith, Jane M.
    Millar, Ewan K. A.
    West, Richard
    McLean, Anna
    Cazet, Aurelie
    Swarbrick, Alexander
    Oakes, Samantha R.
    JOURNAL OF CLINICAL PATHOLOGY, 2013, 66 (06) : 530 - 542
  • [45] Targeting PD-1/PD-L1 in cancer immunotherapy: An effective strategy for treatment of triple-negative breast cancer (TNBC) patients
    Kumar, Sunny
    Chatterjee, Mouli
    Ghosh, Pratyasha
    Ganguly, Kirat K.
    Basu, Malini
    Ghosh, Mrinal K.
    GENES & DISEASES, 2023, 10 (04) : 1318 - 1350
  • [46] Targeting ROR1 for the Imaging of Triple Negative Breast Cancer
    Artschwager, Raik
    Luo, Audrey
    Mun, Joo Sun
    Kalidindi, Teja
    Okpattah, Daniel
    Pillarsetty, Naga Vara Kishore
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [47] Targeting TIGIT and PD-1 in triple negative breast cancer
    Pandey, Apurva Kumari
    Chauvin, Joe Marc
    Brufsky, Adam
    Pagliano, Ornella
    Ka, Mignane
    Menna, Carmine
    McAuliffe, Priscilla
    Zarour, Hassane
    CANCER RESEARCH, 2020, 80 (04)
  • [48] Vaccine targeting HIF1A in triple negative breast cancer
    Ssempala, A.
    EUROPEAN JOURNAL OF CANCER, 2017, 72 : S26 - S26
  • [49] Therapeutic targeting of aberrant sialylation for prevention of chemoresistance and metastasis in triple negative breast cancer
    Pindiprolu, Sai Kiran S. S.
    Madhan, Jitender
    Srinivasarao, Dadi A.
    Dasari, Nagasen
    Kumar, Chirravuri. S. Phani
    Katta, Chantibabu
    Jyothi, Vaskuri G. S. Sainaga
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2023, 86
  • [50] Targeting the glycolytic pathway as an effective therapeutic approach for triple-negative breast cancer
    Pelicano, Helene
    Zhang, Wan
    Hammoudi, Naima
    Pusztai, Lajos
    Dai, Jiale
    Huang, Peng
    CANCER RESEARCH, 2010, 70
12345